• Luigi Mangione withdraws plans for psychiatric defense in murder trial.
• He is accused of shooting UnitedHealthcare CEO Brian Thompson.
• The withdrawal was confirmed a day after initial defense claims.
• The trial is scheduled to begin in September.
• Experts speculate about potential reasons for the legal strategy shift.

Luigi Mangione, accused of fatally shooting UnitedHealthcare CEO Brian Thompson, has reversed his legal strategy by withdrawing plans to use a psychiatric defense in his upcoming murder trial. This decision follows a court hearing where his attorneys had indicated that they would argue he was suffering from "extreme emotional disturbance" at the time of the alleged murder, but they have now opted against that argument at this stage, according to Reuters, BBC, and NPR.

The 28-year-old Mangione has pleaded not guilty to charges of murder and related offenses stemming from the fatal shooting of Thompson on a Manhattan street in December 2024. His attorneys submitted this withdrawal just before a crucial deadline set by Judge Gregory Carro for providing any psychiatric evidence to the prosecution, as reported by Reuters and BBC.

This dramatic shift has raised questions among legal analysts, who noted that it allows Mangione to sidestep the immediate pressures of disclosing psychiatric evaluations while still leaving the door open for potential defense strategies later. However, experts indicate that this withdrawal significantly complicates the defense team's options moving forward, according to NPR.

The case drew considerable media attention partly due to the public outcry over healthcare costs and practices in the United States, making Thompson's murder emblematic of broader frustrations. Trial proceedings are set to begin in September, with significant implications depending on how the defense and prosecution navigate these legal strategies, according to Reuters, BBC, and NPR.